Interface Biologics Inc (IBI) is a company from Toronto, Ontario, Canada that develops medtech and pharmaceutical materials. 
Their surface modification technology is called Endexo, which involves fluorine-based additives that migrate to a material’s surface during polymerization. This non-stick fluorination prevents platelets and bacteria from stic (Read more...)